GNL Gut and Liver
  1. Emre Basar, Henry Mead, Bennett Shum, Ingrid Rauter, Cihan Ay, Adriane Skaletz-Rorowski, Norbert H. Brockmeyer. Biological Barriers for Drug Delivery and Development of Innovative Therapeutic Approaches in HIV, Pancreatic Cancer, and Hemophilia A/B. Pharmaceutics 2024;16:1207
    https://doi.org/10.3390/pharmaceutics16091207
  2. Xintong Zhou, Xiaomin Wang, Qi Sun, Wenfeng Zhang, Cun Liu, Wenzhe Ma, Changgang Sun. Natural compounds: A new perspective on targeting polarization and infiltration of tumor-associated macrophages in lung cancer. Biomedicine & Pharmacotherapy 2022;151:113096
    https://doi.org/10.1016/j.biopha.2022.113096
  3. Runjie Liu, Jianang Li, Liang Liu, Wenquan Wang, Jinbin Jia. Tumor-associated macrophages (TAMs): Constructing an immunosuppressive microenvironment bridge for pancreatic ductal adenocarcinoma (PDAC). Cancer Pathogenesis and Therapy 2024
    https://doi.org/10.1016/j.cpt.2024.07.004
  4. . .
    https://doi.org/
  5. B. Fendl, A.S. Berghoff, M. Preusser, B. Maier. Macrophage and monocyte subsets as new therapeutic targets in cancer immunotherapy. ESMO Open 2023;8:100776
    https://doi.org/10.1016/j.esmoop.2022.100776
  6. Claudia Cerella, Mario Dicato, Marc Diederich. Enhancing personalized immune checkpoint therapy by immune archetyping and pharmacological targeting. Pharmacological Research 2023;196:106914
    https://doi.org/10.1016/j.phrs.2023.106914
  7. Giulio Giustarini, Germaine Teng, Andrea Pavesi, Giulia Adriani. Characterization of 3D heterocellular spheroids of pancreatic ductal adenocarcinoma for the study of cell interactions in the tumor immune microenvironment. Front. Oncol. 2023;13
    https://doi.org/10.3389/fonc.2023.1156769
  8. Shailendra K. Gautam, Surinder K. Batra, Maneesh Jain. Molecular and metabolic regulation of immunosuppression in metastatic pancreatic ductal adenocarcinoma. Mol Cancer 2023;22
    https://doi.org/10.1186/s12943-023-01813-y
  9. Priyadarshini Pathak, Colin Weekes, Jennifer Y Wo. Small steps can lead to substantial breakthroughs: moving the therapeutic needle forward in pancreatic cancer. The Lancet Oncology 2024;25:824
    https://doi.org/10.1016/S1470-2045(24)00290-0
  10. Giulia Lencioni, Alessandro Gregori, Belen Toledo B, Rita Rebelo, Benoit Immordino, Manoj Amrutkar, Cristina P.R. Xavier, Anja Kocijančič, Deo Prakash Pandey, Macarena Perán, Justo P. Castaño, Naomi Walsh, Elisa Giovannetti. Unravelling the complexities of resistance mechanism in pancreatic cancer: insights from in vitro and ex-vivo model systems. Seminars in Cancer Biology 2024
    https://doi.org/10.1016/j.semcancer.2024.09.002
  11. Shunichi Watanabe, Ayaka Takagi, Eiji Yuba, Chie Kojima, Nanako Dei, Akikazu Matsumoto, Jun Tanikawa, Tetsuya Kawamura, Nadeeka H. De Silva, Takeshi Izawa, Takashi Akazawa, Ryoji Kanegi, Shingo Hatoya, Toshio Inaba, Kikuya Sugiura. In vivo transfection of cytokine genes into tumor cells using a synthetic vehicle promotes antitumor immune responses in a visceral tumor model. The FASEB Journal 2023;37
    https://doi.org/10.1096/fj.202202036R
  12. Baishali Tamuli, Sakshi Sharma, Meena Patkar, Subir Biswas. Key players of immunosuppression in epithelial malignancies: Tumor‐infiltrating myeloid cells and γδ T cells. Cancer Reports 2024;7
    https://doi.org/10.1002/cnr2.2066
  13. Robert J. Norgard, Pratha Budhani, Sarah A. O'Brien, Youli Xia, Jessica N. Egan, Brianna Flynn, Joshua R. Tagore, Joseph Seco, Gregory W. Peet, Ania Mikucka, Ruby Wasti, Li-Chuan Chan, Melanie Hinkel, Sandra Martinez-Morilla, Jeanine Pignatelli, Francesca Trapani, Emily Corse, Di Feng, Kaja Kostyrko, Marco H. Hofmann, Kang Liu, Abhishek S. Kashyap. Reshaping the Tumor Microenvironment of KRASG12D Pancreatic Ductal Adenocarcinoma with Combined SOS1 and MEK Inhibition for Improved Immunotherapy Response. 2024;4:1548
    https://doi.org/10.1158/2767-9764.CRC-24-0172
  14. Ying Kang, Emmanuel Boadi Amoafo, Philomena Entsie, Gregory L. Beatty, Elisabetta Liverani. A role for platelets in metabolic reprogramming of tumor-associated macrophages. Front. Physiol. 2023;14
    https://doi.org/10.3389/fphys.2023.1250982
  15. Hampus Andersson, Barnabas Nyesiga, Tova Hermodsson, Karin Enell Smith, Karin Hägerbrand, Malin Lindstedt, Peter Ellmark. Next-generation CD40 agonists for cancer immunotherapy. Expert Opinion on Biological Therapy 2024;24:351
    https://doi.org/10.1080/14712598.2024.2357714
  16. Fatina Siwczak, Charlotte Hiller, Helga Pfannkuche, Marlon R. Schneider. Culture of vibrating microtome tissue slices as a 3D model in biomedical research. J Biol Eng 2023;17
    https://doi.org/10.1186/s13036-023-00357-5
  17. Craig Grobbelaar, Mpho Kgomo, Peace Mabeta. Angiogenesis and Pancreatic Cancer: Novel Approaches to Overcome Treatment Resistance. CCDT 2024;24:1116
    https://doi.org/10.2174/0115680096284588240105051402
  18. Chenglin Lu, Ying Liu, Linxuan Miao, Xiangle Kong, Huili Li, Haoran Chen, Xu Zhao, Bin Zhang, Xiaonan Cui. Research progress on the role of tumor‑associated macrophages in tumor development and their use as molecular targets (Review). Int J Oncol 2023;64
    https://doi.org/10.3892/ijo.2023.5599
  19. Cheng-Zhe Jian, Li Lin, Chia-Lang Hsu, Yu-Hsin Chen, Chiun Hsu, Ching-Ting Tan, Da-Liang Ou. A potential novel cancer immunotherapy: Agonistic anti-CD40 antibodies. Drug Discovery Today 2024;29:103893
    https://doi.org/10.1016/j.drudis.2024.103893
  20. Wenli Zhou, Fengtang Yang, Xiuzhen Zhang. Roles of M1 Macrophages and Their Extracellular Vesicles in Cancer Therapy. Cells 2024;13:1428
    https://doi.org/10.3390/cells13171428
© 2023. Gut and Liver. / Powered by INFOrang Co., Ltd